Advertisement

Oculomotor Dysfunction in Parkinson’s Disease

  • Christopher Kennard
  • Parashkev Nachev
Chapter
Part of the Current Clinical Neurology book series (CCNEU)

Abstract

A disturbance of the oculomotor system is the principal neuro-ophthalmological manifestation of Parkinson’s disease (PD). Although rarely symptomatic, this disturbance is a valuable subject for study because it illuminates two areas of wider interest: first, the nature of the motor and cognitive dysfunction in PD, and second, the role of the basal ganglia in oculomotor control. In this chapter, we shall give a brief overview of the anatomy and physiology of eye movements before proceeding to a detailed examination of the oculomotor abnormalities in patients with PD.

Keywords

Oculomotor system Parkinson’s disease Oculomotor abnormalities Saccades Saccadic hypometria Reflexive saccades 

References

  1. 1.
    Moschovakis AK, Scudder CA, Highstein SM. The microscopic anatomy and physiology of the mammalian saccadic system. Prog Neurobiol. 1996;50(2–3): 133–254.PubMedGoogle Scholar
  2. 2.
    Sparks DL. The brainstem control of saccadic eye movements. Nat Rev Neurosci. 2002;3(12):952–64.PubMedGoogle Scholar
  3. 3.
    Tehovnik EJ, Sommer MA, Chou I. Eye fields in the frontal lobes of primates. Brain Res Rev. 2000;32(2–3): 413–48.PubMedGoogle Scholar
  4. 4.
    Hikosaka O, Takikawa Y, Kawagoe R. Role of the basal ganglia in the control of purposive saccadic eye movements. Physiol Rev. 2000;80(3):953.PubMedGoogle Scholar
  5. 5.
    Hikosaka O, Nakamura K, Nakahara H. Basal ganglia orient eyes to reward. J Neurophysiol. 2006;95(2): 567.PubMedGoogle Scholar
  6. 6.
    Takikawa Y, Kawagoe R, Hikosaka O. Reward-dependent spatial selectivity of anticipatory activity in monkey caudate neurons. J Neurophysiol. 2002;87(1):508.PubMedGoogle Scholar
  7. 7.
    Lauwereyns J, Takikawa Y, Kawagoe R, Kobayashi S, Koizumi M, Coe B, et al. Feature-based anticipation of cues that predict reward in monkey caudate nucleus. Neuron. 2002;33(3):463–73.PubMedGoogle Scholar
  8. 8.
    Lauwereyns J, Watanabe K, Coe B, Hikosaka O. A neural correlate of response bias in monkey caudate nucleus. Nature. 2002;418(6896):413–7.PubMedGoogle Scholar
  9. 9.
    Takikawa Y, Kawagoe R, Itoh H, Nakahara H, Hikosaka O. Modulation of saccadic eye movements by predicted reward outcome. Exp Brain Res. 2002;142(2):284–91.PubMedGoogle Scholar
  10. 10.
    Sato M, Hikosaka O. Role of primate substantia nigra pars reticulata in reward-oriented saccadic eye movement. J Neurosci. 2002;22(6):2363.PubMedGoogle Scholar
  11. 11.
    Ikeda T, Hikosaka O. Reward-dependent gain and bias of visual responses in primate superior colliculus. Neuron. 2003;39(4):693–700.PubMedGoogle Scholar
  12. 12.
    Nakamura K, Hikosaka O. Role of dopamine in the primate caudate nucleus in reward modulation of saccades. J Neurosci. 2006;26(20):5360.PubMedGoogle Scholar
  13. 13.
    Hotson JR, Langston EB, Langston JW. Saccade responses to dopamine in human MPTP-induced parkinsonism. Ann Neurol. 2004;20(4):456–63.Google Scholar
  14. 14.
    Brooks BA, Fuchs AF, Finocchio D. Saccadic eye movement deficits in the MPTP monkey model of Parkinson’s disease. Brain Res. 1986;383(1–2):402–7.PubMedGoogle Scholar
  15. 15.
    Schultz W, Romo R, Scarnati E, Sundström E, Jonsson G, Studer A. Saccadic reaction times, eye-arm coordination and spontaneous eye movements in normal and MPTP-treated monkeys. Exp Brain Res. 1989;78(2): 253–67.PubMedGoogle Scholar
  16. 16.
    Grace AA, Bunney BS. Intracellular and extracellular electrophysiology of nigral dopaminergic neurons–1. Identification and characterization. Neuroscience. 1983;10(2):301–15.PubMedGoogle Scholar
  17. 17.
    Kato M, Miyashita N, Hikosaka O, Matsumura M, Usui S, Kori A. Eye movements in monkeys with local dopamine depletion in the caudate nucleus. I. Deficits in spontaneous saccades. J Neurosci. 1995;15(1):912.PubMedGoogle Scholar
  18. 18.
    Miyashita N, Hikosaka O, Kato M. Visual hemineglect induced by unilateral striatal dopamine deficiency in monkeys. NeuroReport. 1995;6(9):1257.PubMedGoogle Scholar
  19. 19.
    Krauzlis RJ. Recasting the smooth pursuit eye movement system. J Neurophysiol. 2004;91(2):591.PubMedGoogle Scholar
  20. 20.
    Yoshida A, Tanaka M. Neuronal activity in the primate globus pallidus during smooth pursuit eye movements. NeuroReport. 2009;20(2):121.PubMedGoogle Scholar
  21. 21.
    Lynch JC. Pursuit eye movement signals in the basal ganglia. NeuroReport. 2009;20(2):103.PubMedGoogle Scholar
  22. 22.
    Basso MA, Pokorny JJ, Liu P. Activity of substantia nigra pars reticulata neurons during smooth pursuit eye movements in monkeys. Eur J Neurosci. 2005;22(2):448–64.PubMedGoogle Scholar
  23. 23.
    Seno H, Kobayashi S, Inagaki T, Yamamori C, Miyaoka T, Horiguchi J, et al. Parkinson’s disease associated with argyrophilic grains clinically resembling progressive supranuclear palsy: an autopsy case. J Neurol Sci. 2000;178(1):70–4.PubMedGoogle Scholar
  24. 24.
    Highstein S, Cohen B, Mones R. Changes in saccadic eye movements of patients with Parkinson’s disease before and after L-dopa. Trans Am Neurol Assoc. 1969;94:277.PubMedGoogle Scholar
  25. 25.
    DeJong JD, Jones GM. Akinesia, hypokinesia, and bradykinesia in the oculomotor system of patients with Parkinson’s disease. Exp Neurol. 1971;32(1):58–68.PubMedGoogle Scholar
  26. 26.
    Teräväinen H, Calne DB. Studies of parkinsonian movement: 1. Programming and execution of eye movements. Acta Neurol Scand. 2009;62(3):137–48.Google Scholar
  27. 27.
    Shibasaki H, Tsuji S, Kuroiwa Y. Oculomotor abnormalities in Parkinson’s disease. Arch Neurol. 1979;36(6):360.PubMedGoogle Scholar
  28. 28.
    Bronstein AM, Kennard C. Predictive ocular motor control in Parkinson’s disease. Brain. 1985;108(4):925.PubMedGoogle Scholar
  29. 29.
    Crawford T, Goodrich S, Henderson L, Kennard C. Predictive responses in Parkinson’s disease: manual key presses and saccadic eye movements to regular stimulus events. J Neurol Neurosurg Psychiatry. 1989;52(9):1033.PubMedGoogle Scholar
  30. 30.
    Ventre J, Zee DS, Papageorgiou H, Reich S. Abnormalities of predictive saccades in hemi-Parkinson’s disease. Brain. 1992;115(4):1147.PubMedGoogle Scholar
  31. 31.
    Crawford TJ, Henderson L, Kennard C. Abnormalities of nonvisually-guided eye movements in Parkinson’s disease. Brain. 1989;112(6):1573.PubMedGoogle Scholar
  32. 32.
    Kitagawa M, Fukushima J, Tashiro K. Relationship between antisaccades and the clinical symptoms in Parkinson’s disease. Neurology. 1994;44(12):2285.PubMedGoogle Scholar
  33. 33.
    Lueck CJ, Crawford TJ, Henderson L, Van Gisbergen JAM, Duysens J, Kennard C. Saccadic eye movements in Parkinson’s disease: II. Remembered saccades—towards a unified hypothesis? Q J Exp Psychol A. 1992;45(2):211–33.PubMedGoogle Scholar
  34. 34.
    Lueck CJ, Tanyeri S, Crawford TJ, Henderson L, Kennard C. Antisaccades and remembered saccades in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 1990;53(4):284.PubMedGoogle Scholar
  35. 35.
    Nakamura T, Bronstein AM, Lueck C, Marsden CD, Rudge P. Vestibular, cervical and visual remembered saccades in Parkinson’s disease. Brain. 1994;117(6):1423.PubMedGoogle Scholar
  36. 36.
    Kimmig H, Haußmann K, Mergner T, Lücking CH. What is pathological with gaze shift fragmentation in Parkinson’s disease? J Neurol. 2002;249(6):683–92.PubMedGoogle Scholar
  37. 37.
    Shaunak S, O’Sullivan E, Blunt S, Lawden M, Crawford T, Henderson L, et al. Remembered saccades with variable delay in Parkinson’s disease. Mov Disord. 1999;14(1):80–6.PubMedGoogle Scholar
  38. 38.
    Vermersch AI, Rivaud S, Vidailhet M, Bonnet AM, Gaymard B, Agid Y, et al. Sequences of memory-guided saccades in Parkinson’s disease. Ann Neurol. 2004;35(4):487–90.Google Scholar
  39. 39.
    Sawaguchi T, Goldman-Rakic PS. The role of D1-dopamine receptor in working memory: local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task. J Neurophysiol. 1994;71(2):515.PubMedGoogle Scholar
  40. 40.
    O’Sullivan EP, Shaunak S, Henderson L, Hawken M, Crawford TJ, Kennard C. Abnormalities of predictive saccades in Parkinson’s disease. NeuroReport. 1997;8(5):1209.PubMedGoogle Scholar
  41. 41.
    Hodgson TL, Dittrich WH, Henderson L, Kennard C. Eye movements and spatial working memory in Parkinson’s disease. Neuropsychologia. 1999;37(8): 927–38.PubMedGoogle Scholar
  42. 42.
    Hodgson TL, Tiesman B, Owen AM, Kennard C. Abnormal gaze strategies during problem solving in Parkinson’s disease. Neuropsychologia. 2002;40(4): 411–22.PubMedGoogle Scholar
  43. 43.
    Fukushima J, Fukushima K, Miyasaka K, Yamashita I. Voluntary control of saccadic eye movement in patients with frontal cortical lesions and parkinsonian patients in comparison with that in schizophrenics. Biol Psychiatry. 1994;36(1):21–30.PubMedGoogle Scholar
  44. 44.
    Vidailhet M, Rivaud S, Gouider-Khouja N, Pillon B, Bonnet AM, Gaymard B, et al. Eye movements in parkinsonian syndromes. Ann Neurol. 1994;35(4):420.PubMedGoogle Scholar
  45. 45.
    Briand KA, Hening W, Poizner H, Sereno AB. Automatic orienting of visuospatial attention in Parkinson’s disease. Neuropsychologia. 2001;39(11):1240–9.PubMedGoogle Scholar
  46. 46.
    Roll A, Wierzbicka MM, Wolf W. The “gap paradigm” leads to express-like saccadic reaction times in Parkinson’s disease. Exp Brain Res. 1996;111(1): 131–8.PubMedGoogle Scholar
  47. 47.
    Chambers JM, Prescott TJ. Response times for visually guided saccades in persons with Parkinson’s disease: a meta-analytic review. Neuropsychologia. 2009;48(4):887–99.PubMedGoogle Scholar
  48. 48.
    Mosimann UP, Muri RM, Burn DJ, Felblinger J, O’Brien JT, McKeith IG. Saccadic eye movement changes in Parkinson’s disease dementia and dementia with Lewy bodies. Brain. 2005;128(6):1267.PubMedGoogle Scholar
  49. 49.
    Mort DJ, Perry RJ, Mannan SK, Hodgson TL, Anderson E, Quest R, et al. Differential cortical activation during voluntary and reflexive saccades in man. Neuroimage. 2003;18(2):231–46.PubMedGoogle Scholar
  50. 50.
    Deubel H. Separate adaptive mechanisms for the control of reactive and volitional saccadic eye movements. Vision Res. 1995;35(23–24):3529–40.PubMedGoogle Scholar
  51. 51.
    Crevits L, De Ridder K. Disturbed striatoprefrontal mediated visual behaviour in moderate to severe parkinsonian patients. J Neurol Neurosurg Psychiatry. 1997;63(3):296.PubMedGoogle Scholar
  52. 52.
    Briand KA, Strallow D, Hening W, Poizner H, Sereno AB. Control of voluntary and reflexive saccades in Parkinson’s disease. Exp Brain Res. 1999;129(1): 38–48.PubMedGoogle Scholar
  53. 53.
    Rivaud-Pechoux S, Vidailhet M, Brandel JP, Gaymard B. Mixing pro-and antisaccades in patients with parkinsonian syndromes. Brain. 2007;130(1):256.PubMedGoogle Scholar
  54. 54.
    Gibson JM, Pimlott R, Kennard C. Ocular motor and manual tracking in Parkinson’s disease and the effect of treatment. Br Med J. 1987;50(7):853.Google Scholar
  55. 55.
    Rascol O, Clanet M, Montastruc JL, Simonetta M, Soulier-Esteve MJ, Doyon B, et al. Abnormal ocular movements in Parkinson’s disease: evidence for involvement of dopaminergic systems. Brain. 1989;112(5):1193.PubMedGoogle Scholar
  56. 56.
    Michell AW, Xu Z, Fritz D, Lewis SJG, Foltynie T, Williams-Gray CH, et al. Saccadic latency distributions in Parkinson’s disease and the effects of L-dopa. Exp Brain Res. 2006;174(1):7–18.PubMedGoogle Scholar
  57. 57.
    Hood AJ, Amador SC, Cain AE, Briand KA, Al-Refai AH, Schiess MC, et al. Levodopa slows prosaccades and improves antisaccades: an eye movement study in Parkinson’s disease. J Neurol Neurosurg Psychiatry. 2007;78(6):565.PubMedGoogle Scholar
  58. 58.
    Sauleau P, Pollak P, Krack P, Courjon JH, Vighetto A, Benabid AL, et al. Subthalamic stimulation improves orienting gaze movements in Parkinson’s disease. Clin Neurophysiol. 2008;119(8):1857–63.PubMedGoogle Scholar
  59. 59.
    Temel Y, Visser-Vandewalle V, Carpenter RH. Saccadometry: a novel clinical tool for quantification of the motor effects of subthalamic nucleus stimulation in Parkinson’s disease. Exp Neurol. 2009;216(2):481.PubMedGoogle Scholar
  60. 60.
    Rivaud-Pechoux S, Vermersch AI, Gaymard B, Ploner CJ, Bejjani BP, Damier P, et al. Improvement of memory guided saccades in parkinsonian patients by high frequency subthalamic nucleus stimulation. J Neurol Neurosurg Psychiatry. 2000;68(3):381.PubMedGoogle Scholar
  61. 61.
    Straube A, Ditterich J, Oertel W, Kupsch A. Electrical stimulation of the posteroventral pallidum influences internally guided saccades in Parkinson’s disease. J Neurol. 1998;245(2):101–5.PubMedGoogle Scholar
  62. 62.
    Yugeta A, Terao Y, Fukuda H, Hikosaka O, Yokochi F, Okiyama R, et al. Effects of STN stimulation on the initiation and inhibition of saccade in Parkinson disease. Neurology. 2010;74(9):743.PubMedGoogle Scholar
  63. 63.
    Corin MS, Elizan TS, Bender MB. Oculomotor function in patients with Parkinson’s disease. J Neurol Sci. 1972;15(3):251–65.PubMedGoogle Scholar
  64. 64.
    Gibson JM, Kennard C. Quantitative study of “on-off” fluctuations in the ocular motor system in Parkinson’s disease. Adv Neurol. 1987;45:329–33.PubMedGoogle Scholar
  65. 65.
    Sharpe JA, Fletcher WA, Lang AE, Zackon DH. Smooth pursuit during dose-related on-off fluctuations in Parkinson’s disease. Neurology. 1987;37(8):1389.PubMedGoogle Scholar
  66. 66.
    White OB, Saint-Cyr JA, Tomlinson RD, Sharpe JA. Ocular motor deficits in Parkinson’s disease: II. Control of the saccadic and smooth pursuit systems. Brain. 1983;106(3):571.PubMedGoogle Scholar
  67. 67.
    Waterston JA, Barnes GR, Grealy MA, Collins S. Abnormalities of smooth eye and head movement control in Parkinson’s disease. Ann Neurol. 1996;39(6):749.PubMedGoogle Scholar
  68. 68.
    Bare M, Brázdil M, Kaovsk P, Jurák P, Daniel P, Kukleta M, et al. The effect of apomorphine administration on smooth pursuit ocular movements in early Parkinsonian patients. Parkinsonism Relat Disord. 2003;9(3):139–44.Google Scholar
  69. 69.
    Krack P, Marion MH. “Apraxia of lid opening,” a focal eyelid dystonia: clinical study of 32 patients. Mov Disord. 1994;9(6):610.PubMedGoogle Scholar
  70. 70.
    Hirayama M, Kumano T, Aita T, Nakagawa H, Kuriyama M. Improvement of apraxia of eyelid opening by wearing goggles. Lancet. 2000;356(9239):1413.PubMedGoogle Scholar
  71. 71.
    Racette BA, Gokden M, Tychsen L, Perlmutter JS. Convergence insufficiency in idiopathic Parkinson s disease responsive to levodopa. Strabismus. 1999;7(3):169–74.PubMedGoogle Scholar
  72. 72.
    Brett FM, Henson C, Staunton H. Familial diffuse Lewy body disease, eye movement abnormalities, and distribution of pathology. Arch Neurol. 2002;59(3):464.PubMedGoogle Scholar
  73. 73.
    de Bruin VM, Lees AJ, Daniel SE. Diffuse Lewy body disease presenting with supranuclear gaze palsy, parkinsonism, and dementia: a case report. Mov Disord. 1992;7(4):355.PubMedGoogle Scholar
  74. 74.
    Fearnley JM, Revesz T, Brooks DJ, Frackowiak RS, Lees AJ. Diffuse Lewy body disease presenting with a supranuclear gaze palsy. J Neurol Neurosurg Psychiatry. 1991;54(2):159.PubMedGoogle Scholar
  75. 75.
    Lewis AJ, Gawel MJ. Diffuse Lewy body disease with dementia and oculomotor dysfunction. Mov Disord. 1990;5(2):143.PubMedGoogle Scholar
  76. 76.
    Cordato NJ, Halliday GM, McCann H, Davies L, Williamson P, Fulham M, et al. Corticobasal syndrome with tau pathology. Mov Disord. 2001;16(4):656–67.PubMedGoogle Scholar
  77. 77.
    Oyanagi K, Chen KM, Craig UK, Yamazaki M, Perl DP. Parkinsonism, dementia and vertical gaze palsy in a Guamanian with atypical neuroglial degeneration. Acta Neuropathol. 2000;99(1):73–80.PubMedGoogle Scholar
  78. 78.
    Averbuch-Heller L, Stahl JS, Hlavin ML, Leigh RJ. Square-wave jerks induced by pallidotomy in parkinsonian patients. Neurology. 1999;52(1):185.PubMedGoogle Scholar
  79. 79.
    Averbuch-Heller L, Helmchen C, Horn AK, Leigh RJ, Büttner-Ennerver JA. Slow vertical saccades in motor neuron disease: correlation of structure and function. Ann Neurol. 1998;44(4):641.PubMedGoogle Scholar
  80. 80.
    Wenning GK, Jellinger K, Litvan I. Supranuclear gaze palsy and eyelid apraxia in postencephalitic parkinsonism. J Neural Transm. 1997;104(8):845–65.PubMedGoogle Scholar
  81. 81.
    Grant MP, Cohen M, Petersen RB, Halmagyi GM, McDougall A, Tusa RJ, et al. Abnormal eye movements in Creutzfeldt-Jakob disease. Ann Neurol. 1993;34(2):192.PubMedGoogle Scholar
  82. 82.
    Zarei M, Nouraei S, Caine D, Hodges J, Carpenter R. Neuropsychological and quantitative oculometric study of a case of sporadic Creutzfeldt–Jakob disease at predementia stage. J Neurol Neurosurg Psychiatry. 2002;73(1):56.PubMedGoogle Scholar
  83. 83.
    Rinne JO, Lee MS, Thompson PD, Marsden CD. Corticobasal degeneration: a clinical study of 36 cases. Brain. 1994;117(5):1183.PubMedGoogle Scholar
  84. 84.
    Merchut MP, Brigell M. Olivopontocerebellar atrophy presenting with hemiparkinsonian ocular motor signs. J Neuroophthalmol. 1990;10(3):210.Google Scholar
  85. 85.
    Rottach KG, Riley DE, DiScenna AO, Zivotofsky AZ, Leigh RJ. Dynamic properties of horizontal and vertical eye movements in parkinsonian syndromes. Ann Neurol. 1996;39(3):368.PubMedGoogle Scholar
  86. 86.
    Helmchen C, Schwekendiek A, Pramstaller PP, Hedrich K, Klein C, Rambold H. Blink amplitude but not saccadic hypometria indicates carriers of Parkin mutations. J Neurol. 2006;253(8):1071–5.PubMedGoogle Scholar
  87. 87.
    Blekher T, Weaver M, Rupp J, Nichols WC, Hui SL, Gray J, et al. Multiple step pattern as a biomarker in Parkinson disease. Parkinsonism Relat Disord. 2009;15(7):506–10.PubMedGoogle Scholar
  88. 88.
    Shimizu N, Cohen B, Bala SP, Mendoza M, Yahr MD. Ocular dyskinesias in patients with Parkinson’s disease treated with levodopa. Ann Neurol. 2004;1(2):167–71.Google Scholar
  89. 89.
    Linazasoro G, Van Blercom N, Lasa A, Indakoetxea B, Ruiz J. Levodopa-induced ocular dyskinesias in Parkinson’s disease. Mov Disord. 2002;17(1):186–7.PubMedGoogle Scholar
  90. 90.
    Blekher T, Siemers E, Abel LA, Yee RD. Eye movements in Parkinson’s disease: before and after pallidotomy. Invest Ophthalmol Vis Sci. 2000;41(8):2177.PubMedGoogle Scholar
  91. 91.
    Averbuch-Heller L, Paulson GW, Daroff RB, Leigh RJ. Whipple’s disease mimicking progressive supranuclear palsy: the diagnostic value of eye movement recording. J Neurol Neurosurg Psychiatry. 1999;66(4):532.PubMedGoogle Scholar
  92. 92.
    Anagnostou E, Sporer B, Steude U, Kempermann U, Buttner U, Botzel K. Contraversive eye deviation during deep brain stimulation of the globus pallidus internus. Neurology. 2001;56(10):1396.PubMedGoogle Scholar
  93. 93.
    Harris CM. Does saccadic undershoot minimize saccadic flight-time? A Monte-Carlo study. Vision Res. 1995;35(5):691–701.PubMedGoogle Scholar
  94. 94.
    Straube A, Deubel H, Ditterich J, Eggert T. Cerebellar lesions impair rapid saccade amplitude adaptation. Neurology. 2001;57(11):2105.PubMedGoogle Scholar
  95. 95.
    Desmurget M, Pelisson D, Grethe JS, Alexander GE, Urquizar C, Prablanc C, et al. Functional adaptation of reactive saccades in humans: a PET study. Exp Brain Res. 2000;132(2):243–59.PubMedGoogle Scholar
  96. 96.
    Desmurget M, Pelisson D, Urquizar C, Prablanc C, Alexander GE, Grafton ST. Functional anatomy of saccadic adaptation in humans. Nat Neurosci. 1998;1:524–8.PubMedGoogle Scholar
  97. 97.
    Robinson FR, Noto CT, Bevans SE. Effect of visual error size on saccade adaptation in monkey. J Neurophysiol. 2003;90(2):1235.PubMedGoogle Scholar
  98. 98.
    Straube A, Fuchs AF, Usher S, Robinson FR. Characteristics of saccadic gain adaptation in rhesus macaques. J Neurophysiol. 1997;77(2):874.PubMedGoogle Scholar
  99. 99.
    Ketcham CJ, Hodgson TL, Kennard C, Stelmach GE. Memory-motor transformations are impaired in Parkinson’s disease. Exp Brain Res. 2003;149(1):30–9.PubMedGoogle Scholar
  100. 100.
    McAuley JH. The physiological basis of clinical deficits in Parkinson’s disease. Prog Neurobiol. 2003;69(1):27–48.PubMedGoogle Scholar
  101. 101.
    Mink JW. The basal ganglia: focused selection and inhibition of competing motor programs. Prog Neurobiol. 1996;50(4):381–425.PubMedGoogle Scholar
  102. 102.
    MacAskill MR, Anderson TJ, Jones RD. Adaptive modification of saccade amplitude in Parkinson’s disease. Brain. 2002;125(7):1570.PubMedGoogle Scholar
  103. 103.
    MacAskill MR, Anderson TJ, Jones RD. Saccadic adaptation in neurological disorders. Prog Brain Res. 2002;140:417.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Department of Clinical NeurosciencesUniversity of OxfordOxfordUK
  2. 2.Institute of NeurologyUniversity CollegeLondonUK

Personalised recommendations